TSX:WEEDPharmaceuticals
Reassessing Canopy Growth (TSX:WEED) Valuation After U.S. Cannabis Reclassification and Turnaround Progress
U.S. President Donald Trump’s executive order moving cannabis to Schedule III has completely changed the backdrop for Canopy Growth (TSX:WEED), reshaping expectations around taxes, banking access, and the company’s already improving turnaround story.
See our latest analysis for Canopy Growth.
Despite the upbeat narrative around Schedule III and Canopy’s cost cuts, momentum has been choppy. A recent 7 day share price return of minus 32.83 percent has offset a 30 day share price return of 9.2...